Product wrap: Turkish capital-protected fund targets pharmaceutical stocks

EUROPE Isbank is distributing a capital-protected structured fund in Turkey. The one-year product is linked to a basket comprising five shares from the pharmaceutical and biotechnology sector (Bayer, Bristol-Myers Squibb, Novartis, Roche, Pfizer). At maturity, it offers a minimum capital return of 104%, plus 75% in the rise of the basket, capped at an overall maximum return of 130%. An annual fee of maximum 2.19% applies. SIP Nordic Fondkommission launched Huippujohtajat Autocall II in Finland